Carpenter LR, Moy JN, Roebuck KA
Effects of NAD + precursor-based clinical interventions on the liver and isolated PBMCs Pioneering studies primarily conducted with healthy participants over short-term periods were designed to assess the dose tolerance and safety of NAD + precursors, particularly NR [76] (Table 2)
I think these data show us why some patients do want to stay on opioids because it may be helping to boost their reward system deficits, at least a little bit. If you are wondering whether the pain levels, psychological measures or other clinical symptoms were different between the two patient groups, the answer is NO
Safe, dermatologist-approveddesign for at-home treatments
But so as far as your formulation, the other ingredients and safety and all of that, is there endocrine disruptors or ingredients of concern